Courteney K. Lai

1.0k total citations
8 papers, 104 citations indexed

About

Courteney K. Lai is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Courteney K. Lai has authored 8 papers receiving a total of 104 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Hematology and 1 paper in Oncology. Recurrent topics in Courteney K. Lai's work include Acute Myeloid Leukemia Research (4 papers), CRISPR and Genetic Engineering (3 papers) and Protein Degradation and Inhibitors (3 papers). Courteney K. Lai is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), CRISPR and Genetic Engineering (3 papers) and Protein Degradation and Inhibitors (3 papers). Courteney K. Lai collaborates with scholars based in Canada, Germany and United States. Courteney K. Lai's co-authors include R. Keith Humphries, Michael Heuser, Tobias Maetzig, Amit Sharma, Razif Gabdoulline, Arnold Ganser, Jens Rüschmann, Nidhi Jyotsana, Euan Ramsay and Arnold Kloos and has published in prestigious journals such as Blood, PLoS ONE and Molecular Therapy.

In The Last Decade

Courteney K. Lai

8 papers receiving 102 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Courteney K. Lai Canada 6 68 50 14 13 11 8 104
Claudia Lanauze United States 2 110 1.6× 28 0.6× 13 0.9× 20 1.5× 18 1.6× 2 142
Konstanze Doehner Germany 4 68 1.0× 41 0.8× 12 0.9× 18 1.4× 9 0.8× 14 101
Patrick Blaney United States 6 78 1.1× 58 1.2× 24 1.7× 23 1.8× 7 0.6× 16 109
Diego Chacon Fajardo Australia 6 72 1.1× 35 0.7× 21 1.5× 6 0.5× 9 0.8× 9 106
Matthieu Duchmann France 4 46 0.7× 61 1.2× 18 1.3× 7 0.5× 10 0.9× 11 92
Stephanie Nance United States 7 73 1.1× 20 0.4× 13 0.9× 21 1.6× 26 2.4× 9 125
Valentina Robustelli Italy 6 63 0.9× 37 0.7× 13 0.9× 39 3.0× 28 2.5× 13 103
Sofia Bakogianni United States 2 186 2.7× 39 0.8× 25 1.8× 16 1.2× 11 1.0× 2 208
Ryan Monahan United States 3 47 0.7× 73 1.5× 6 0.4× 22 1.7× 24 2.2× 5 102
Marie‐Agnès Collonge‐Rame France 5 23 0.3× 36 0.7× 13 0.9× 13 1.0× 8 0.7× 11 69

Countries citing papers authored by Courteney K. Lai

Since Specialization
Citations

This map shows the geographic impact of Courteney K. Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Courteney K. Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Courteney K. Lai more than expected).

Fields of papers citing papers by Courteney K. Lai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Courteney K. Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Courteney K. Lai. The network helps show where Courteney K. Lai may publish in the future.

Co-authorship network of co-authors of Courteney K. Lai

This figure shows the co-authorship network connecting the top 25 collaborators of Courteney K. Lai. A scholar is included among the top collaborators of Courteney K. Lai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Courteney K. Lai. Courteney K. Lai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Jyotsana, Nidhi, Amit Sharma, Arnold Kloos, et al.. (2020). Targeted Inhibition of the NUP98-NSD1 Fusion Oncogene in Acute Myeloid Leukemia. Cancers. 12(10). 2766–2766. 32 indexed citations
2.
Maetzig, Tobias, et al.. (2017). Lentiviral Fluorescent Genetic Barcoding for Multiplex Fate Tracking of Leukemic Cells. Molecular Therapy — Methods & Clinical Development. 6. 54–65. 13 indexed citations
3.
Maetzig, Tobias, Jens Rüschmann, Courteney K. Lai, et al.. (2017). A Lentiviral Fluorescent Genetic Barcoding System for Flow Cytometry-Based Multiplex Tracking. Molecular Therapy. 25(3). 606–620. 14 indexed citations
4.
Xiang, Ping, Wei Wei, Tobias Maetzig, et al.. (2017). A knock-in mouse strain facilitates dynamic tracking and enrichment of MEIS1. Blood Advances. 1(24). 2225–2235. 5 indexed citations
5.
Sharma, Amit, Nidhi Jyotsana, Courteney K. Lai, et al.. (2016). Pyrimethamine as a Potent and Selective Inhibitor of Acute Myeloid Leukemia Identified by High-throughput Drug Screening. Current Cancer Drug Targets. 16(9). 818–828. 18 indexed citations
6.
Sharma, Amit, Nidhi Jyotsana, Courteney K. Lai, et al.. (2014). High-Throughput Drug Screening Identifies Pyrimethamine As a Potent and Selective Inhibitor of Acute Myeloid Leukemia. Blood. 124(21). 2304–2304. 1 indexed citations
7.
Lai, Courteney K., Florian Kuchenbauer, Bob Argiropoulos, et al.. (2014). Cell Fate Decisions in Malignant Hematopoiesis: Leukemia Phenotype Is Determined by Distinct Functional Domains of the MN1 Oncogene. PLoS ONE. 9(11). e112671–e112671. 9 indexed citations
8.
Yung, Eric, Sanja Sekulovic, Bob Argiropoulos, et al.. (2010). Delineating domains and functions of NUP98 contributing to the leukemogenic activity of NUP98-HOX fusions. Leukemia Research. 35(4). 545–550. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026